Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;147(4):644e-657e.
doi: 10.1097/PRS.0000000000007762.

Current Use of Cosmetic Toxins to Improve Facial Aesthetics

Lindsay E Janes  1 , Lauren M Connor  1 , Amir Moradi  1 , Mohammed Alghoul  1
Affiliations

Current Use of Cosmetic Toxins to Improve Facial Aesthetics

Lindsay E Janes et al. Plast Reconstr Surg. .

Abstract

Learning objectives: After studying this article, the participant should be able to: 1. Compare and contrast the various types of botulinum toxin on the market. 2. Appropriately select patients for treatment with cosmetic botulinum toxin. 3. Understand the common injection patterns for treating various regions of the face with cosmetic botulinum toxin. 4. List the complications associated with treating various regions of the face with cosmetic botulinum toxin.

Summary: Nonsurgical rejuvenation of the face with botulinum toxin is one of the most commonly performed procedures in the United States. This article reviews the current evidence in treating different regions of the face: upper face, lower face, masseter, and platysma. Dosing and complications associated with different facial regions are reviewed.

PubMed Disclaimer

References

    1. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum -A exotoxin. J Dermatol Surg Oncol. 1992;18:17–21.
    1. American Society of Plastic Surgeons. 2017 plastic surgery statistics report. . Available at: https://www.plasticsurgery.org/documents/News/Statistics/2017/plastic-su... . Accessed August 21, 2020.
    1. Barinaga M. Secrets of secretion revealed. Science. 1993;260:487–489.
    1. Söllner T, Rothman JE. Neurotransmission: Harnessing fusion machinery at the synapse. Trends Neurosci. 1994;17:344–348.
    1. Rosales RL, Bigalke H, Dressler D. Pharmacology of botulinum toxin: Differences between type A preparations. Eur J Neurol. 2006;13(Suppl 1):2–10.

Publication types

Substances

LinkOut - more resources